Figure 3.

Kaplan-Meier curves showing cumulative incidences of fatigue (all grades) and grade 3‒4 neutropenia. (A): Fatigue in patients treated with palbociclib plus fulvestrant. (B): Grade 3‒4 neutropenia in patients treated with palbociclib plus fulvestrant. (C): Patients treated with palbociclib plus fulvestrant who had grade ≤2 neutropenia within the first 4 cycles and grade 3–4 neutropenia after cycle 4. “Neutropenia” includes the following preferred terms: “neutropenia,” “neutrophil count decreased.” The Kaplan-Meier estimator was used to estimate the cumulative incidence in the plot.